Several multiple sclerosis drugs covered by Pharmacare in every province except B.C.
When Deborah Stefanek was 38 years old, the mother of four from Kimberley, B.C. was diagnosed with relapsing remitting multiple sclerosis.
That was in 2018, and she hoped a healthy lifestyle would enable her to stay off medication. She changed her diet and started an exercise routine. But after an MRI last fall showed her disease is progressing, Stefanek’s neurologist recommended she begin taking a new medication called Kisempta.
The drug’s manufacturer agreed to temporarily provide the medication free of charge while Stefanek looked into coverage through Pharmacare and private insurance.
“And it came back that my husband’s insurance would only cover 45 per cent of the cost of Kesimpta, which would mean we would have to pay $19,000 out of pocket, because B.C. Pharmacare doesn’t cover it,” said Stefanek.
She was shocked to learn every province in Canada covers Kisempta under their Pharmacare plans except B.C. It’s the same situation for a similar drug called Ocrevus. Stefanek’s friend Andrea Rollheiser, who also has RRMS, was told by her neurologist that Ocrevus is the best drug for her, but it too isn’t covered by B.C. Pharmacare.
The province’s health critic Shirley Bond says that’s unacceptable.
“As patients in British Columbians look across the country, British Columbia is an island on this issue unto itself. And it very hard for people to understand why other jurisdictions, including the one next door to us, can figure out how to cover these drugs,” said Bond, who believes it’s all about cost.
Roche Canada, the maker of Ocrevus, is hoping the B.C. government will reverse course and cover both drugs, which are approved by Health Canada and have been proven to reduce the number and severity of MS relapses.
“All of the other provincial governments have made the decision to make this medicine available, they felt it was a valuable medicine for those living with MS in thier province. And we are equally hopeful that we can have a discussion with the government of British Columbia so that a similar decision can be made,” said Roche Canada president and CEO Brigitte Nolet.
Bond says the opposition will continue to push the government to reconsider its decision on Kesimpta and Ocrevus. And she hopes patients keep speaking out.
“I think it is important for people to speak up and remind the government, and certainly we are doing that as well, that other jurisdictions have figured this out, have approved it. And MS patients, particularly those that suffer from relapse, are being treated differently in B.C. than the rest of the country,” said Bond.
Stefanek says with the bridge financing from the drug company now over, she can only remain on Kestimpa if it’s covered by Pharmacare.
“As it stands right now, we cannot afford that $19,000. So currently, I’m not on the medication,” she said.
And that has her worried she’s at risk for relapse, which could leave her bedridden and unable to care for her kids.
“I need to keep moving, being able to support them and provide for them,” Stefanek said. “If I’m sick, I’m no good to anybody.”
CTVNews.ca Top Stories
NDP calls out Conservatives for effort to quash pharmacare legislation
The federal New Democrats are calling out Conservative Leader Pierre Poilievre and his party for trying to block the bill that could pave the way for millions of Canadians to access birth control and diabetes coverage.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.
Mediterranean staple may lower your risk of death from dementia, study finds
A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists.
An El Nino-less summer is coming. Here's what that could mean for Canada
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
DEVELOPING Hamas accepts Gaza ceasefire proposal from Egypt and Qatar
Hamas said it has accepted a ceasefire deal proposed by Egypt and Qatar which seeks to halt the seven-month war with Israel in Gaza.
Stamp prices rise for the third time in five years amid financial woes for Canada Post
Canada Post is increasing stamp prices for the third time since 2019, a move the Crown corporation says is a "reality" of its sales-based revenue structure.
For the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene.
B.C. court date set for 3 accused of murdering Sikh activist Hardeep Singh Nijjar
Three suspects accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar last year are scheduled to appear in court in Surrey on Tuesday.
Ontario MPP asked again to leave Ontario legislature over keffiyeh, Speaker loosens ban
An Ontario MPP was asked again to leave the Ontario legislature on Monday for wearing a keffiyeh, a garment that was banned by the Speaker last month due to its political symbolism.